Boswellin® (Boswelia resin extract) food supplement. Advice: Not recommended for children under 12 years of age or for pregnant or breastfeeding women. Properties: Boswellin® is a registered trademark owned by the prestigious Sabinsa Corp. that offers a Boswellia extract standardized in boswellic acids (pentacyclic triterpenic acids), in addition to a wide variety of active ingredients for maximum results. Boswellic acids inhibit 5-lipoxygenase, and therefore inhibit the synthesis of pro-inflammatory substances, such as 5-hydroxyeicosatetraenoic acid (5-HETE) and leukotriene B4 (LTB4). Directions for use: Adults, 1 to 2 capsules daily. Children 12 years and older, 1 capsule daily. Preferably with meals. Foods rich in fat facilitate the absorption of Boswellia preparations.